The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Agoraphobia Market Research Report 2025
Synopsis
Agoraphobia (ag-uh-ruh-FOE-be-uh) is a type of anxiety disorder in which you fear and avoid places or situations that might cause you to panic and make you feel trapped, helpless or embarrassed.
The global Agoraphobia market was valued at US$ 607.2 million in 2023 and is anticipated to reach US$ 740.8 million by 2030, witnessing a CAGR of 2.4% during the forecast period 2024-2030.
North American market for Agoraphobia is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Agoraphobia is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Agoraphobia in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Agoraphobia include Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Pfizer, GlaxoSmithKline, Johnson＆Johnson, Sandoz, Apotex and Mylan Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Agoraphobia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Agoraphobia.
Report Scope
The Agoraphobia market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Agoraphobia market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Agoraphobia companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Pfizer
GlaxoSmithKline
Johnson＆Johnson
Sandoz
Apotex
Mylan Pharmaceuticals
Segment by Type
Selective Serotonin Reuptake Inhibitors
Norepinephrine Reuptake Inhibitors
Others
Segment by Application
Hospitals
Private clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Agoraphobia companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Agoraphobia (ag-uh-ruh-FOE-be-uh) is a type of anxiety disorder in which you fear and avoid places or situations that might cause you to panic and make you feel trapped, helpless or embarrassed.
The global Agoraphobia market was valued at US$ 607.2 million in 2023 and is anticipated to reach US$ 740.8 million by 2030, witnessing a CAGR of 2.4% during the forecast period 2024-2030.
North American market for Agoraphobia is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Agoraphobia is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Agoraphobia in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Agoraphobia include Eli Lilly, Bristol-Myers Squibb, AstraZeneca, Pfizer, GlaxoSmithKline, Johnson＆Johnson, Sandoz, Apotex and Mylan Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Agoraphobia, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Agoraphobia.
Report Scope
The Agoraphobia market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Agoraphobia market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Agoraphobia companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Pfizer
GlaxoSmithKline
Johnson＆Johnson
Sandoz
Apotex
Mylan Pharmaceuticals
Segment by Type
Selective Serotonin Reuptake Inhibitors
Norepinephrine Reuptake Inhibitors
Others
Segment by Application
Hospitals
Private clinics
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Agoraphobia companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Agoraphobia Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Selective Serotonin Reuptake Inhibitors
1.2.3 Norepinephrine Reuptake Inhibitors
1.2.4 Others
1.3 Market by Application
1.3.1 Global Agoraphobia Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Private clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Agoraphobia Market Perspective (2019-2030)
2.2 Agoraphobia Growth Trends by Region
2.2.1 Global Agoraphobia Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Agoraphobia Historic Market Size by Region (2019-2024)
2.2.3 Agoraphobia Forecasted Market Size by Region (2025-2030)
2.3 Agoraphobia Market Dynamics
2.3.1 Agoraphobia Industry Trends
2.3.2 Agoraphobia Market Drivers
2.3.3 Agoraphobia Market Challenges
2.3.4 Agoraphobia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Agoraphobia Players by Revenue
3.1.1 Global Top Agoraphobia Players by Revenue (2019-2024)
3.1.2 Global Agoraphobia Revenue Market Share by Players (2019-2024)
3.2 Global Agoraphobia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Agoraphobia Revenue
3.4 Global Agoraphobia Market Concentration Ratio
3.4.1 Global Agoraphobia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Agoraphobia Revenue in 2023
3.5 Agoraphobia Key Players Head office and Area Served
3.6 Key Players Agoraphobia Product Solution and Service
3.7 Date of Enter into Agoraphobia Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Agoraphobia Breakdown Data by Type
4.1 Global Agoraphobia Historic Market Size by Type (2019-2024)
4.2 Global Agoraphobia Forecasted Market Size by Type (2025-2030)
5 Agoraphobia Breakdown Data by Application
5.1 Global Agoraphobia Historic Market Size by Application (2019-2024)
5.2 Global Agoraphobia Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Agoraphobia Market Size (2019-2030)
6.2 North America Agoraphobia Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Agoraphobia Market Size by Country (2019-2024)
6.4 North America Agoraphobia Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Agoraphobia Market Size (2019-2030)
7.2 Europe Agoraphobia Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Agoraphobia Market Size by Country (2019-2024)
7.4 Europe Agoraphobia Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Agoraphobia Market Size (2019-2030)
8.2 Asia-Pacific Agoraphobia Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Agoraphobia Market Size by Region (2019-2024)
8.4 Asia-Pacific Agoraphobia Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Agoraphobia Market Size (2019-2030)
9.2 Latin America Agoraphobia Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Agoraphobia Market Size by Country (2019-2024)
9.4 Latin America Agoraphobia Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Agoraphobia Market Size (2019-2030)
10.2 Middle East & Africa Agoraphobia Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Agoraphobia Market Size by Country (2019-2024)
10.4 Middle East & Africa Agoraphobia Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Agoraphobia Introduction
11.1.4 Eli Lilly Revenue in Agoraphobia Business (2019-2024)
11.1.5 Eli Lilly Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Detail
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Agoraphobia Introduction
11.2.4 Bristol-Myers Squibb Revenue in Agoraphobia Business (2019-2024)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Agoraphobia Introduction
11.3.4 AstraZeneca Revenue in Agoraphobia Business (2019-2024)
11.3.5 AstraZeneca Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Agoraphobia Introduction
11.4.4 Pfizer Revenue in Agoraphobia Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Agoraphobia Introduction
11.5.4 GlaxoSmithKline Revenue in Agoraphobia Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Development
11.6 Johnson＆Johnson
11.6.1 Johnson＆Johnson Company Detail
11.6.2 Johnson＆Johnson Business Overview
11.6.3 Johnson＆Johnson Agoraphobia Introduction
11.6.4 Johnson＆Johnson Revenue in Agoraphobia Business (2019-2024)
11.6.5 Johnson＆Johnson Recent Development
11.7 Sandoz
11.7.1 Sandoz Company Detail
11.7.2 Sandoz Business Overview
11.7.3 Sandoz Agoraphobia Introduction
11.7.4 Sandoz Revenue in Agoraphobia Business (2019-2024)
11.7.5 Sandoz Recent Development
11.8 Apotex
11.8.1 Apotex Company Detail
11.8.2 Apotex Business Overview
11.8.3 Apotex Agoraphobia Introduction
11.8.4 Apotex Revenue in Agoraphobia Business (2019-2024)
11.8.5 Apotex Recent Development
11.9 Mylan Pharmaceuticals
11.9.1 Mylan Pharmaceuticals Company Detail
11.9.2 Mylan Pharmaceuticals Business Overview
11.9.3 Mylan Pharmaceuticals Agoraphobia Introduction
11.9.4 Mylan Pharmaceuticals Revenue in Agoraphobia Business (2019-2024)
11.9.5 Mylan Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
